Editorial Policy

Where claims come from

Articles are built from randomized trials, systematic reviews, and clinical guidelines from bodies like NICE, ACOG, the Menopause Society, and the FDA. We work from the studies themselves, not summaries of summaries. When the evidence is thin, mixed, or applies mostly to a different population, the article says so. A claim we can’t tie to a source doesn’t get published.

How we cite

Every article lists its sources, numbered in the text and linked at the end. References follow AMA style, and we verify each one, including authors, journal, year, and DOI, against PubMed and CrossRef before it appears. The source count shown at the top of each article is the real count from its reference list, nothing else.

Medical review

Veradene articles are medically reviewed by Amy Bingaman, MD, MSCP, FACOG, a board-certified gynecologist and Menopause Society Certified Practitioner. Medical review checks the main answer, clinical context, benefits and risks, monitoring, red flags, and whether the cited evidence supports the claims that matter to a health decision. The author and medical reviewer are identified separately on each article.

Use of AI

We use AI tools in research and drafting. People check every article for accuracy and source traceability before it goes out. Care decisions are made by licensed clinicians, never by software.

Corrections

When new evidence changes the picture, we revise the article and update its date. If you find an error, write to care@veradene.com. We read those.

What we don’t do

No urgency tactics. No guaranteed outcomes. No talking down other treatments to sell ours. If an option outside our offering fits the evidence better for a given situation, the article says that too.